Calcineurin as a multifunctional regulator

Journal of Biochemistry

Volumn 131, Issue 1, 2002, Pages 1-15

  Shibasaki, Futoshi ^a   Hallin, Ulrika ^a,b   Uchino, Hiroyuki ^a,c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Bc1 2; Calcineurin; Cardiac hypertrophy; Immunosuppressant; Ischemia

Indexed keywords

CALCINEURIN; CALCIUM; CYCLOSPORIN A; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; TACROLIMUS; TRANSCRIPTION FACTOR NFAT;

APOPTOSIS; BRAIN ISCHEMIA; CALCIUM SIGNALING; CARDIOVASCULAR SYSTEM; CELL DEATH; CELL SURVIVAL; HUMAN; IMMUNE SYSTEM; MITOCHONDRION; MUSCLE TISSUE; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION;

MAMMALIA;

EID: 0036171986     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a003063     Document Type: Review

References (180)

1. 2+- and protein modulator-activated cyclic nucleotide phosphodiesterase
2. Calcineurin: A calcium- and calmodulin-binding protein of the nervous system
3. Calcineurin
4. High levels of a heat-labile calmodulin-binding protein (CaM-BP80) in bovine neostriatum
5. Calcineurin regulation of synaptic function: From ion channels to transmitter release and gene transcription
6. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
7. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity
8. 2+-activated cell death in mammalian cells
9. 2+-induced apoptosis through calcineurin dephosphorylation of BAD
10. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia
11. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat
12. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
13. Novel protein phosphatases that may participate in cell signaling
14. Calcineurin in human brain and its relation to extrapyramidal system. Immunohistochemical study on postmortem human brains
15. Distinct cellular expression of calcineurin A alpha and A beta in rat brain
16. Molecular cloning and chromosomal mapping of the human gene for the testis-specific catalytic subunit of calmodulin-dependent protein phosphatase (calcineurin A)
17. The structure of the B subunit of calcineurin
18. 15N nuclear magnetic resonance backbone assignments and secondary structure of human calcineurin B
19. Characterization of the calcium-binding sites of calcineurin B
20. Structure and expression of two isoforms of murine calmodulin-dependent protein phosphatase regulatory subunit (calcineurin B)
21. Myristoylation of calcineurin B is not required for function or interaction with immunophilin-immunosuppressant complexes in the yeast Saccharomyces cerevisiae
22. A cluster of basic amino acid residues in calcineurin B participates in the binding of calcineurin to phosphatidylserine vesicles
23. 2+- and myristoylation-dependent association of calcineurin with phosphatidylserine
24. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex
25. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex
26. The mechanism of action of cyclosporin A and FK506
27. Mapping of the ilnmunophilin-immunosuppressant site of interaction on calcineurin
28. Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes
29. The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation
30. Interaction of FKBP12-FK506 with calcineurin A at the B subunit-binding domain
31. FK506 binding protein mutational analysis. Defining the surface residue contributions to stability of the calcineurin co-complex
32. Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition
33. Cyclophilin residues that affect noncompetitive inhibition of the protein serine phosphatase activity of calcineurin by the cyclophilin-cyclosporin A complex
34. Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A
35. Multiple forms of calcineurin, a brain isozyme of the calmodulin-stimulated protein phosphatase
36. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4
37. Differential subcellular localization of neural isoforms of the catalytic subunit of calmodulin-dependent protein phosphatase (calcineurin) in central nervous system neurons: Immunohistochemistry on formalin-fixed paraffin sections employing antigen retrieval by microwave irradiation
38. The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: Relationship to calcineurin
39. Expression of the calmodulin-dependent protein phosphatase, calcineurin, in rat brain: Developmental patterns and the role of nigrostriatal innervation
40. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain
41. Characterization of bovine brain calmodulin-dependent protein phosphatase
42. 2+-dependent inactivation of calcineurin in brain
43. Superoxide dismutase protects calcineurin from inactivation
44. 2+- and stimulus duration-dependent switch for hippocampal gene expression
45. Functional domain structure of calcineurin A: Mapping by limited proteolysis
46. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
47. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
48. Beta-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes
49. Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin
50. Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B
51. A multifunctional calmodulin-stimulated phosphatase
52. Potential role of calcineurin for brain ischemia and traumatic injury
53. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity
54. Effects of mutant rat dynamin on endocytosis
55. The calcium/calmodulin-dependent protein phosphatase calcineurin is the major Elk-1 phosphatase
56. Dephosphorylation of the small heat shock protein hsp25 by calcium/calmodulin-dependent (type 2B) protein phosphatase
57. Dephosphorylation of microtubule-associated protein 2, tau factor, and tubulin by calcineurin
58. 2+-dependent phosphatase
59. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun
60. Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp)
61. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2
62. Characterization of the calmodulin-binding and catalytic domains in skeletal muscle myosin light chain kinase
63. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin
64. Measurement of calcineurin phosphatase activity in cell extracts
65. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy
66. FK506 binding protein associated with the calcium release channel (ryanodine receptor)
67. 2- flux
68. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein
69. FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain
70. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein
71. A calcineurin homologous protein inhibits GTPase-stimulated Na-H exchange
72. Inhibition of calcineurin phosphatase activity by a calcineurin B homologous protein
73. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes
74. Cain, a novel physiologic protein inhibitor of calcineurin
75. A conserved family of calcineurin regulators
76. Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans
77. A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart
78. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways
79. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling
80. A viral mechanism for inhibition of the cellular phosphatase calcineurin
81. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices
82. Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate
83. GABAA receptors control the excitability of neuronal populations
84. Synaptic plasticity: LTP and LTD
85. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory
86. Immunophilins and the nervous system
87. Regulation of calcineurin by growth cone calcium waves controls neurite extension
88. Cytoskeletal changes in the brains of mice lacking calcineurin A alpha
89. Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex
90. Protein synthesis and memory: A review
91. Evidence for a role of calmodulin in the regulation of prolactin gene expression
92. Molecular enhancement of memory formation
93. Involvement of the brain-derived neurotrophic factor/TrkB pathway in neuroprotecive effect of cyclosporin A in forebrain ischemia
94. 2+ dysregulation with brain aging
95. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin
96. Genetic approaches to memory storage
97. 2+- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils
98. Control of the alpha 5 beta 1 integrin/fibronectin interaction in vitro by the serine/threonine protein phosphatase calcineurin
99. +-ATPase activity in renal tubule cells
100. +-ATPase that results in its activation in cerebellar neurons in culture
101. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
102. Chromatin changes in apoptosis
103. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death
104. Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide
105. Is the cell death pathway triggered by the mitochondrion or the endoplasmic reticulum?
106. Delayed neuronal death in the gerbil hippocampus following ischemia
107. Temporal profile of neuronal damage in a model of transient forebrain ischemia
108. Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model
109. Experimental cerebral ischemia in mongolian gerbils. I. Light microscopic observations
110. Thresholds of focal cerebral ischemia in awake monkeys
111. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion
112. Acidosis and ischemic brain damage
113. Role of hyperglycaemia-related acidosis in ischaemic brain damage
114. Progressive shrinkage of the thalamus following middle cerebral artery occlusion in rats
115. Atrophy of the ipsilateral substantia nigra following middle cerebral artery occlusion in the rat
116. Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist
117. The ionic basis of neurocytotoxic damage
118. Calcium: Still center-stage in hypoxic-ischemic neuronal death
119. Normal and abnormal calcium homeostasis in neurons: A basis for the pathophysiology of traumatic and ischemic central nervous system injury
120. Intracellular signal transduction in the postischemic brain
121. Isolation of an ischemia-induced gene and early disturbance of mitochondrial DNA expression after transient forebrain ischemia
122. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain
123. Reactive oxygen species and the central nervous system
124. Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis
125. Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons
126. 2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons
127. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity
128. The mitochondrial permeability transition
129. Mitochondrial transport of cations: Channels, exchangers, and permeability transition
130. Mitochondrial control of cell death
131. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart
132. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy
133. Gene expression induced by cerebral ischemia: An apoptotic perspective
134. Double identity for proteins of the Bcl-2 family
135. Mitochondria and apoptosis
136. Mitochondria as regulators of apoptosis: Doubt no more
137. Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat
138. Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia
139. 2+/calmodulin-dependent protein kinase II and calcineurin in the hippocampus of rat brain after transient forebrain ischemia
140. Calcineurin in the adult rat hippocampus: Different distribution in CA1 and CA3 subfields
141. Alteration in the immunoreactivity of the calcineurin subunits after ischemic hippocampal damage
142. Immunocytochemical localization of calcineurin in the adult and developing primary visual cortex of cats
143. High level calcineurin activity predisposes neuronal cells to apoptosis
144. Cyclosporin A protects against ischemia-reperfusion injury in the brain
145. Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats
146. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death
147. Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia
148. 2+ response amplitude and duration
149. Calcineurin signaling and muscle remodeling
150. Alterations in calcium handling in cardiac hypertrophy and heart failure
151. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins
152. Calcineurin and beyond: Cardiac hypertrophic signaling
153. Calcium, calcineurin, and the control of transcription
154. The murine DSCR1-like (Down syndrome candidate region 1) gene family: Conserved synteny with the human orthologous genes
155. Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis
156. The transcription factor NF-ATc is essential for cardiac valve formation
157. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
158. Control of cardiac gene expression by mechanical stress
159. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure
160. Calcineurin activity is required for the initiation of skeletal muscle differentiation
161. Calcineurin is required for skeletal muscle hypertrophy
162. A calcineurin-dependent transcriptional pathway controls keletal muscle fiber type
163. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy
164. Transcription factors of the NFAT family: Regulation and function
165. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun
166. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1
167. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3
168. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway
169. Nuclear protein import
170. CRM1 is responsible for intracellular transport mediated by the nuclear export signal
171. NF-AT activation requires suppression of Crm1-dependent export by calcineurin
172. Nucleocytoplasmic shuttling and the control of NF-AT signaling
173. Protein phosphatase type 2B (calcineurin)-mediated, FK506-sensitive regulation of intracellular ions in yeast is an important determinant for adaptation to high salt stress conditions
174. Calcineurin acts through the CRZ1/TCN1-encoded transcription factor to regulate gene expression in yeast
175. Tcn1p/Crz1p, a calcineurin-dependent transcription factor that differentially regulates gene expression in Saccharomyces cerevisiae
176. 2+ homeostasis of yeast cells
177. + in fission yeast: Mutant defects in cytokinesis, cell polarity, mating and spindle pole body positioning
178. 2+/calmodulin-dependent phosphoprotein phosphatases is required for adaptation to pheromone
179. The calmodulin-dependent protein phosphatase catalytic subunit (calcineurin A) is an essential gene in Aspergillus nidulans
180. Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2